IT’S BEEN A RACE between two pharma giants to get an HPV (Human papillomavirus) vaccine into the market. Last Thursday, Merck & Co., Inc. jumped ahead of GlaxoSmithKline. That was the day that the Food and Drug Administration (FDA) cleared Merck’s Gardisil® for use in the United States. GlaxoSmithKline indicates that it expects to submit […]
- "Technology Update"
Merck’s HPV Vaccine Cleared For Use by FDA Last Week
It’s the beginning of a new cycle of change in cervical cancer screening and treatment
- By Robert Michel
- > From the Volume XIII No. 8 - June 12, 2006 Issue
